Organ-on-Chip Market Poised for Robust Growth, Driven by Alternatives to Animal Testing and Increasing R&D Funding
• Global organ-on-chip market expected to reach $631M by 2029, 38.6% CAGR • Key growth drivers include alternative methods to animal testing and increasing funding • North America accounted for largest market share due to funding, infrastructure, key players • Liver-on-chip segment dominated by focus on drug metabolism and hepatotoxicity testing • Standardization and mimicking complex tissues remain key challenges